High-dose corticosteroids for acute cytomegalovirus-associated transverse myelitis in the immunocompetent patient: a case report and systematic review
We present an immunocompetent patient with transverse myelitis (TM) during acute cytomegalovirus (CMV) infection, as evidenced by a reactive serum CMV IgM and CMV viremia. The patient had an excellent outcome after receiving only high-dose methylprednisolone. Given concerns that practitioners may have around the use of immunosuppressive therapy for this potentially infectious myelopathy, we systematically reviewed the literature to assess outcomes after administration of high-dose corticosteroids to this population. Despite severe disease at clinical nadir with inability to ambulate, immunocompetent patients with acute CMV-associated TM who received high-dose corticosteroids had good clinical outcomes 1 month to 1 year after presentation.
KeywordsCytomegalovirus Myelitis Methylprednisolone Corticosteroids Immunocompetent
Compliance with ethical standards
Conflicts of interest
The authors declare they have no conflicts of interest.
- Kestenbaum M, Auriel EE, Perloock H, Karni A (2015) Suspected CMV associated myelitis in immunocompetent adult without supporting PCR from the CSF. Austin J Clin Neurol 2(5):1042Google Scholar
- Scott TF, Frohman EM, De Seze J, Gronseth GS, Weinshenker BG, Therapeutics and Technology Assessment Subcommittee of American Academy of Neurology (2011) Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 77(24):2128–2134CrossRefGoogle Scholar